Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Nephrology | Oncology | Family Medicine | Urology
Search Medical Condition
Bladder Cancer Clinical Trials
A listing of Bladder Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (469) clinical trials
Liver Cirrhosis – Cancer Diagnostic Test
A research study is evaluating an investigational blood sample diagnostic test combined with liver ultrasounds, compared to ultrasounds alone, for the detection of liver cancer in people with liver cirrhosis.
Muscle- Invasive Bladder Cancer (MIBC)
People with bladder cancer are asked to participate in a research study being conducted by Montefiore Medical Center.
Urothelial cancer with FGFR Mutations
People with urothelial cancer are asked to participate in a research study being conducted by White Plains Hospital.
A Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Subjects With High Risk Non-muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy
Patients who wish to enroll in a research study should discuss the possibilities with their urologist. The TUCC Clinical Research Department staff remains in constant communication with patients throughout their enrollment in clinical trials. These patients receive all study related medication and procedures at no cost. Participation is voluntary and ...
Phase I Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor
- This is the first study where BAY1163877 is given to humans. Impact of the study is to evaluate if patients with advanced solid cancers show advanced clinical benefit under the treatment with the pan FGFR inhibitor. Patients (all comers) will receive the study drug treatment in a dose-escalation scheme ...
Muscle-Invasive Bladder Cancer
People with bladder cancer are asked to participate in a research study being conducted by Northwell Health.
BCG Naïve Non-Muscle Invasive Bladder Cancer
People with bladder cancer are asked to participate in a research study being conducted by Montefiore Medical Center.
A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib Plus Pembrolizumab Versus Pemigatinib Alone Versus Standard of Care as First-Line Treatment for Metastatic or Unresectable Urothelial Carcinoma in Cisplatin-Ineligible Participants Whose Tumors Express FGFR3 Mutation or Rearrangement
The purpose of this study is to evaluate the safety and efficacy of pemigatinib plus pembrolizumab or pemigatinib alone versus the standard of care for participants with metastatic or unresectable urothelial carcinoma who are not eligible to receive cisplatin, are harboring FGFR3 mutation or rearrangement, and who have not received ...
AHEP0731: Combination Chemotherapy in Treating Young Patients with Newly Diagnosed Liver Cancer
For more information please visit: http://clinicaltrials.gov/ct2/show/NCT00980460?term=AHEP0731&rank=1
Study of Copanlisib in Hepatic or Renal Impairment
To evaluate the pharmacokinetics and safety of copanlisib in subjects with impaired hepatic or renal function in comparison to healthy subjects
